Stockreport

Sage CEO hopes for a Prozac moment with experimental depression drug [CNBC]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF Sage Therapeutics CEO Jeff Jonas is optimistic about a depression drug the company is developing. Recent positive trial results have given the company reas [Read more]